Actelion Ltd. · Allschwil, Baselland Switzerland (Swiss: ATLN)
| Gewerbestrasse 16 | Phone: +41-61-565-6565 |
| Allschwil, Baselland | Fax: +41-61-565-6500 |
| 4123 | |
| Switzerland | 
Map This Company |
Actelion Ltd. Rankings
| Swiss Market |
Company Description
Drugmaker Actelion is anything but neutral in its fight against life-threatening diseases. The Swiss drugmaker develops and markets small molecule drugs in a number of therapeutic areas, including cardiovascular disease, oncology, and autoimmune disease. Actelion has several products on the market: It sells Tracleer worldwide and Ventavis in the US as treatments for pulmonary arterial hypertension (PAH), a serious disease characterized by high blood pressure in the arteries connecting the heart and lungs. The company also markets Zavesca, which treats an inherited metabolic disorder called Gaucher disease. Actelion has sales and marketing subsidiaries in more than 25 countries around the world.
Actelion Ltd. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Swiss: ATLN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2009 Employees | 2,260 |
Executives
21 executives listed for Actelion Ltd.'s Allschwil, Baselland location.
| Chairman | Robert Cawthorn | |
|---|---|---|
| Vice Chairman | André Mueller | |
| CEO and Director | Jean-Paul Clozel |